433 related articles for article (PubMed ID: 16523414)
1. Biochemical markers of endothelial activation in primary hyperparathyroidism.
Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
[TBL] [Abstract][Full Text] [Related]
2. Endothelial activation markers soluble E-selectin and von Willebrand factor in primary hyperparathyroidism.
Lumachi F; Zanella S; Cella G; Casonato A; Fallo F
In Vivo; 2011; 25(2):279-82. PubMed ID: 21471547
[TBL] [Abstract][Full Text] [Related]
3. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors.
Meyer AA; Kundt G; Steiner M; Schuff-Werner P; Kienast W
Pediatrics; 2006 May; 117(5):1560-7. PubMed ID: 16651309
[TBL] [Abstract][Full Text] [Related]
4. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
5. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
Nadar SK; Al Yemeni E; Blann AD; Lip GY
Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
[TBL] [Abstract][Full Text] [Related]
6. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.
Ogard CG; Engelmann MD; Kistorp C; Nielsen SL; Vestergaard H
Clin Endocrinol (Oxf); 2005 Nov; 63(5):493-8. PubMed ID: 16268799
[TBL] [Abstract][Full Text] [Related]
8. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
Doshi SN; Moat SJ; Lewis MJ; McDowell IF; Giddings JC; Goodfellow J
Int J Cardiol; 2004 Apr; 94(2-3):203-7. PubMed ID: 15093982
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
10. Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.
Bhatia GS; Sosin MD; Patel JV; Grindulis KA; Khattak FH; Davis RC; Lip GY
Int J Cardiol; 2009 May; 134(1):97-103. PubMed ID: 18501982
[TBL] [Abstract][Full Text] [Related]
11. Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study.
Thorand B; Baumert J; Döring A; Schneider A; Chambless L; Löwel H; Kolb H; Koenig W
Thromb Haemost; 2006 Jan; 95(1):134-41. PubMed ID: 16543972
[TBL] [Abstract][Full Text] [Related]
12. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma concentrations of N-terminal pro-B-type natriuretic peptide in patients with mild primary hyperparathyroidism.
Almqvist EG; Becker C; Bondeson AG; Bondeson L; Svensson J; Svensson SE
Clin Endocrinol (Oxf); 2006 Dec; 65(6):760-6. PubMed ID: 17121527
[TBL] [Abstract][Full Text] [Related]
14. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.
Roldán V; Marín F; García-Herola A; Lip GY
Thromb Res; 2005; 116(4):321-5. PubMed ID: 16038717
[TBL] [Abstract][Full Text] [Related]
15. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
[TBL] [Abstract][Full Text] [Related]
16. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
[TBL] [Abstract][Full Text] [Related]
17. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
18. Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
J Intern Med; 2007 Jan; 261(1):82-90. PubMed ID: 17222171
[TBL] [Abstract][Full Text] [Related]
19. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.
Thorand B; Baumert J; Chambless L; Meisinger C; Kolb H; Döring A; Löwel H; Koenig W;
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):398-405. PubMed ID: 16322530
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers.
Morange PE; Renucci JF; Charles MA; Aillaud MF; Giraud F; Grimaux M; Juhan-Vague I
Thromb Haemost; 2001 Jun; 85(6):999-1003. PubMed ID: 11434709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
